Comparison of intravitreal bevacizumab and ranibizumab used for myopic choroidal neovascularization: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials

BACKGROUND: To evaluate the effect of intravitreal bevacizumab (IVB) and ranibizumab (IVR) for the treatment of choroidal neovascularization (CNV) secondary to pathologic myopia (PM) by meta-analysis. METHODS: Pertinent publications of randomized controlled trials (RCTs) were identified through syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiuming, Li, Haoyu, Du, Yi, He, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709001/
https://www.ncbi.nlm.nih.gov/pubmed/30896642
http://dx.doi.org/10.1097/MD.0000000000014905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709001/
https://www.ncbi.nlm.nih.gov/pubmed/30896642
http://dx.doi.org/10.1097/MD.0000000000014905

Ejemplares similares